FAQs ABOUT MIGITUS 5MG
What is MIGITUS 5MG and why is it given?
MIGITUS 5MG is a combination of flunarizine and propranolol which belongs to the group of medicines called calcium channel blockers and beta-blockers respectively, which is used as a prophylactic medication for migraine which is generally characterized by symptoms such as nausea, weakness, sensitivity to light and sound.
Who should avoid taking MIGITUS 5MG?
MIGITUS 5MG is not recommended for use in patients having depressive illness, parkinson’s disease (brain disorder), urinary tract obstruction, low blood pressure, diabetes mellitus, hepatic impairment, second- or third-degree heart block, bronchial asthma, pregnant and breastfeeding women. Consult your doctor before taking MIGITUS 5MG.
What are the common side effects of MIGITUS 5MG?
The most common side-effects of using MIGITUS 5MG are increase in body weight, increased appetite, blocked or runny nose, problems with sleeping, sleepiness, nausea, and constipation. Consult your doctor if any of these worsens or doesn’t improve.
Can MIGITUS 5MG cause weight gain?
MIGITUS 5MG can cause weight gain when used for longer period of time. Therefore, it is advised to maintain a healthy eating habit and have a balanced diet while taking MIGITUS 5MG.
Can MIGITUS 5MG be given to children?
No, MIGITUS 5MG is not recommended for use in children and adolescents (below 18 years of age). If MIGITUS 5MG is accidentally ingested by a child or adolescent, go to the hospital immediately and consult the doctor for further management.